Page 2 - Glycomimetics Inc News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Glycomimetics inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Glycomimetics Inc Today - Breaking & Trending Today

Glycomimetics wilts on missed acute myeloid leukemia phase III

Top-line data from Glycomimetics Inc.’s pivotal phase III study of uproleselan in 388 patients with relapsed/refractory acute myeloid leukemia missed its primary endpoint. The data crippled the stock, which closed at the low point of its 10-year existence. ....

Glycomimetics Inc , Glycomimetics Inc , Acute Myeloid Leukemia , Fast Track Designation , Breakthrough Therapy , Small Molecule ,

GlycoMimetics (GLYC) Set to Announce Quarterly Earnings on Thursday

GlycoMimetics (GLYC) Set to Announce Quarterly Earnings on Thursday
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

United States , Glycomimetics Inc , Glycomimetics Company Profile , Get Free Report , Capital One Financial , Glycomimetics Daily ,

Why Is GlycoMimetics Stock Falling In Pre-market?

GlycoMimetics, Inc. (GLYC) reported topline results from Phase 3 global pivotal study of uproleselan in 388 patients with Relapsed/Refractory Acute Myeloid Leukemia. ....

More Such Health News , Glycomimetics Inc , Refractory Acute Myeloid ,